Pathogen profiles and molecular epidemiology of respiratory viruses in Japanese inpatients with community-acquired pneumonia

Respiratory Investigation

Volumn 54, Issue 4, 2016, Pages 255-263

  Kurai, Daisuke ^a   Sasaki, Yoshiko ^b   Saraya, Takeshi ^a   Ishii, Haruyuki ^a   Tsukagoshi, Hiroyuki ^b   Kozawa, Kunihisa ^c   Ryo, Akihide ^c   Ishioka, Taisei ^d   Kuroda, Makoto ^e   Oishi, Kazunori ^e   Takizawa, Hajime ^a   Kimura, Hirokazu ^c,e  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Takasaki Control Office   (Japan)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Community acquired pneumonia; Metapneumovirus; Pathogen profile; Respiratory virus

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN RHINOVIRUS; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PHYLOGENY; RESPIRATORY FAILURE; RESPIRATORY VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; UNIVERSITY HOSPITAL; VIRUS DETECTION; VIRUS INFECTION; VIRUS VIRULENCE; COMMUNITY ACQUIRED INFECTION; JAPAN; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA; VIROLOGY; VIRUS PNEUMONIA;

AGED; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INPATIENTS; JAPAN; MALE; MIDDLE AGED; PNEUMONIA; PNEUMONIA, VIRAL;

EID: 84961223533     PISSN: 22125345     EISSN: 22125353     Source Type: Journal    
DOI: 10.1016/j.resinv.2016.01.001     Document Type: Article

References (50)

1. Mandell, L.A., Wunderink, R.G., Anzueto, A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Inf Dis 44 (2007), S27–S72.
2. Lim, W.S., Baudouin, S.V., George, R.C., et al. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 64 (2009), 1–55.
3. Torres, A., Blasi, F., Peetermans, W.E., et al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis 33 (2014), 1065–1079.
4. Fukuyama, H., Yamashiro, S., Kinjo, K., et al. Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study. BMC Infect Dis, 14, 2014, 534.
5. Paganin, F., Lilienthal, F., Bourdin, A., et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 24 (2004), 779–785.
6. Cillóniz, C., Ewig, S., Polverino, E., et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 66 (2011), 340–346.
7. Manoha, C., Espinosa, S., Aho, S.L., et al. Epidemiological and clinical features of hMPV, RSV and RVs infections in young children. J Clin Virol 38 (2007), 221–226.
8. Jacques, J., Bouscambert-Duchamp, M., Moret, H., et al. Association of respiratory picornaviruses with acute bronchiolitis in French infants. J Clin Virol 35 (2006), 463–466.
9. Khadadah, M., Essa, S., Higazi, Z., et al. Respiratory syncytial virus and human rhinoviruses are the major causes of severe lower respiratory tract infections in Kuwait. J Med Virol 82 (2010), 1462–1467.
10. Jain, S., Williams, D.J., Arnold, S.R., et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372 (2015), 835–845.
11. Kurai, D., Saraya, T., Ishii, H., et al. Virus-induced exacerbations in asthma and COPD. Front Microbiol, 4, 2013, 293.
12. Takahashi, K., Suzuki, M., Minhle, N., et al. The incidence and aetiology of hospitalized community-acquired pneumonia among Vietnamese adults: a prospective surveillance in Central Vietnam. BMC Infect Dis, 13, 2013, 296.
13. Williams, J.V., Martino, R., Rabella, N., et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 192 (2005), 1061–1065.
14. Lieberman, D., Shimoni, A., Shemer-Avni, Y., et al. Respiratory viruses in adults with community-acquired pneumonia. Chest 138 (2010), 811–816.
15. Dowell, S.F., Anderson, L.J., Gary, H.E. Jr., et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 174 (1996), 456–462.
16. Almirall, J., Bolíbar, I., Vidal, J., et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 15 (2000), 757–763.
17. Jain, S., Self, W.H., Wunderink, R.G., et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373 (2015), 415–427.
18. Fine, M.J., Auble, T.E., Yealy, D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997), 243–250.
19. Peret, T.C., Boivin, G., Li, Y., et al. Characterization of human metapneumovirus isolated from patients in North America. J Infect Dis 185 (2002), 1660–1663.
20. Ishiko, H., Shimada, Y., Yonaha, M., et al. Molecular diagnosis of human enteroviruses by phylogeny-based classification by use of the VP4 sequence. J Infect Dis 185 (2002), 744–754.
21. Sullender, W.M., Sun, L., Anderson, L.J., Analysis of respiratory syncytial virus genetic variability with amplified cDNAs. J Clin Microbiol 31 (1993), 1224–1231.
22. WHO information for molecular diagnosis of influenza virus. 〈http://www.who.int/influenza/gisrs_laboratory/molecular_diagnosis/en/〉; 2015 [accessed 22.06.15].
23. Bellau-Pujol, S., Vabret, A., Legrand, L., et al. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods 126 (2005), 53–63.
24. McIver, C.J., Jacques, C.F., Chow, S.S., et al. Development of Multiplex PCRs for detection of common viral pathogens and agents of congenital infections. J Clin Microbiol 43 (2005), 5102–5110.
25. Lam, W.Y., Yeung, A.C., Tang, J.W., et al. Rapid multiplex nested PCR for detection of respiratory viruses. J Clin Microbiol 45 (2007), 3631–3640.
26. Allander, T., Tammi, M.T., Eriksson, M., et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 102 (2005), 12891–12896.
27. Van Scoy, R.E., Bacterial sputum cultures. A clinician viewpoint. Mayo Clin Proc 52 (1977), 39–41.
28. Huijskens, E.G., Koopmans, M., Palmen, F.M., et al. The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia. J Med Microbiol 63 (2014), 441–452.
29. Lim, W.S., Macfarlane, J.T., Boswell, T.C., et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56 (2001), 296–301.
30. Ishida, T., Hashimoto, T., Arita, M., et al. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 114 (1998), 1588–1593.
31. Morimoto, K., Suzuki, M., Ishifuji, T., et al. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS One, 10, 2015, e0122247.
32. Boivin, G., De Serres, G., Hamelin, M.E., et al. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 44 (2007), 1152–1158.
33. Arakawa, M., Okamoto-Nakagawa, R., Toda, S., et al. Molecular epidemiological study of human rhinovirus species A, B and C from patients with acute respiratory illnesses in Japan. J Med Microbiol 61 (2012), 410–419.
34. Kiyota, N., Kushibuchi, I., Kobayashi, M., et al. Genetic analysis of the VP4/VP2 coding region in human rhinovirus species C in patients with acute respiratory infection in Japan. J Med Microbiol 62 (2013), 610–617.
35. Miyaji, Y., Kobayashi, M., Sugai, K., et al. Severity of respiratory signs and symptoms and virus profiles in Japanese children with acute respiratory illness. Microbiol Immunol 57 (2013), 811–821.
36. Cunha, B.A., Cytomegalovirus pneumonia: community-acquired pneumonia in immunocompetent hosts. Infect Dis Clin North Am 24 (2010), 147–158.
37. Baughman, R.P., Cytomegalovirus: the monster in the closet?. Am J Respir Crit Care Med 156 (1997), 1–2.
38. Angeles Marcos, M., Camps, M., Pumarola, T., et al. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther 11 (2006), 351–359.
39. Jennings, L.C., Anderson, T.P., Beynon, K.A., et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 63 (2008), 42–48.
40. Johansson, N., Kalin, M., Hedlund, J., Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia. Scand J Infect Dis 43 (2011), 609–615.
41. Seki, M., Yanagihara, K., Higashiyama, Y., et al. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J 24 (2004), 143–149.
42. Kukavica-Ibrulj, I., Hamelin, M.E., Prince, G.A., et al. Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J Virol 83 (2009), 1341–1349.
43. Verkaik, N.J., Nguyen, D.T., de Vogel, C.P., et al. Streptococcus pneumoniae exposure is associated with human metapneumovirus seroconversion and increased susceptibility to in vitro HMPV infection. Clin Microbiol Infect 17 (2011), 1840–1844.
44. Mallia, P., Footitt, J., Sotero, R., et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186 (2012), 1117–1124.
45. Templeton, K.E., Scheltinga, S.A., van den Eeden, W.C., et al. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 41 (2005), 345–351.
46. George, S.N., Garcha, D.S., Mackay, A.J., et al. Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J 44 (2014), 87–96.
47. de Roux, A., Marcos, M.A., Garcia, E., et al. Viral community-acquired pneumonia in nonimmunocompromised adults. Chest 125 (2004), 1343–1351.
48. Johnstone, J., Majumdar, S.R., Fox, J.D., et al. Viral infection in adults hospitalized with community-acquired pneumonia. Chest 134 (2008), 1141–1148.
49. Tashiro, M., McKimm-Breschkin, J.L., Saito, T., et al. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007. Antivir Ther 14 (2009), 751–761.
50. Self, W.H., Williams, D.J., Zhu, Y., et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis 213 (2016), 584–591.